3.25.3 html 501 394 1 false 153 0 false 15 false false R1.htm 0000001 - Document - Cover Sheet http://royaltypharma.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY Statements 6 false false R7.htm 9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY (Parenthetical) Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYParenthetical CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY (Parenthetical) Statements 7 false false R8.htm 9952157 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 9952158 - Disclosure - Organization and Purpose Sheet http://royaltypharma.com/role/OrganizationandPurpose Organization and Purpose Notes 9 false false R10.htm 9952159 - Disclosure - Summary of Significant Accounting Policies Sheet http://royaltypharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 9952160 - Disclosure - Internalization Sheet http://royaltypharma.com/role/Internalization Internalization Notes 11 false false R12.htm 9952161 - Disclosure - Share-Based Compensation Sheet http://royaltypharma.com/role/ShareBasedCompensation Share-Based Compensation Notes 12 false false R13.htm 9952162 - Disclosure - Shareholders' Equity Sheet http://royaltypharma.com/role/ShareholdersEquity Shareholders' Equity Notes 13 false false R14.htm 9952163 - Disclosure - Available for Sale Debt Securities Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecurities Available for Sale Debt Securities Notes 14 false false R15.htm 9952164 - Disclosure - Fair Value Measurements and Financial Instruments Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstruments Fair Value Measurements and Financial Instruments Notes 15 false false R16.htm 9952165 - Disclosure - Financial Royalty Assets Sheet http://royaltypharma.com/role/FinancialRoyaltyAssets Financial Royalty Assets Notes 16 false false R17.htm 9952166 - Disclosure - Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets Sheet http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssets Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets Notes 17 false false R18.htm 9952167 - Disclosure - Non-Consolidated Affiliates Sheet http://royaltypharma.com/role/NonConsolidatedAffiliates Non-Consolidated Affiliates Notes 18 false false R19.htm 9952168 - Disclosure - Research and Development Funding Expense Sheet http://royaltypharma.com/role/ResearchandDevelopmentFundingExpense Research and Development Funding Expense Notes 19 false false R20.htm 9952169 - Disclosure - Borrowings Sheet http://royaltypharma.com/role/Borrowings Borrowings Notes 20 false false R21.htm 9952170 - Disclosure - Earnings per Share Sheet http://royaltypharma.com/role/EarningsperShare Earnings per Share Notes 21 false false R22.htm 9952171 - Disclosure - Indirect Cash Flow Sheet http://royaltypharma.com/role/IndirectCashFlow Indirect Cash Flow Notes 22 false false R23.htm 9952172 - Disclosure - Commitments and Contingencies Sheet http://royaltypharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 23 false false R24.htm 9952173 - Disclosure - Related Party Transactions Sheet http://royaltypharma.com/role/RelatedPartyTransactions Related Party Transactions Notes 24 false false R25.htm 9952174 - Disclosure - Subsequent Event Sheet http://royaltypharma.com/role/SubsequentEvent Subsequent Event Notes 25 false false R26.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 26 false false R27.htm 9955511 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://royaltypharma.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://royaltypharma.com/role/SummaryofSignificantAccountingPolicies 27 false false R28.htm 9955512 - Disclosure - Internalization (Tables) Sheet http://royaltypharma.com/role/InternalizationTables Internalization (Tables) Tables http://royaltypharma.com/role/Internalization 28 false false R29.htm 9955513 - Disclosure - Share-Based Compensation (Tables) Sheet http://royaltypharma.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://royaltypharma.com/role/ShareBasedCompensation 29 false false R30.htm 9955514 - Disclosure - Shareholders' Equity (Tables) Sheet http://royaltypharma.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://royaltypharma.com/role/ShareholdersEquity 30 false false R31.htm 9955515 - Disclosure - Available for Sale Debt Securities (Tables) Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecuritiesTables Available for Sale Debt Securities (Tables) Tables http://royaltypharma.com/role/AvailableforSaleDebtSecurities 31 false false R32.htm 9955516 - Disclosure - Fair Value Measurements and Financial Instruments (Tables) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsTables Fair Value Measurements and Financial Instruments (Tables) Tables http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstruments 32 false false R33.htm 9955517 - Disclosure - Financial Royalty Assets (Tables) Sheet http://royaltypharma.com/role/FinancialRoyaltyAssetsTables Financial Royalty Assets (Tables) Tables http://royaltypharma.com/role/FinancialRoyaltyAssets 33 false false R34.htm 9955518 - Disclosure - Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets (Tables) Sheet http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssetsTables Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets (Tables) Tables http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssets 34 false false R35.htm 9955519 - Disclosure - Borrowings (Tables) Sheet http://royaltypharma.com/role/BorrowingsTables Borrowings (Tables) Tables http://royaltypharma.com/role/Borrowings 35 false false R36.htm 9955520 - Disclosure - Earnings per Share (Tables) Sheet http://royaltypharma.com/role/EarningsperShareTables Earnings per Share (Tables) Tables http://royaltypharma.com/role/EarningsperShare 36 false false R37.htm 9955521 - Disclosure - Indirect Cash Flow (Tables) Sheet http://royaltypharma.com/role/IndirectCashFlowTables Indirect Cash Flow (Tables) Tables http://royaltypharma.com/role/IndirectCashFlow 37 false false R38.htm 9955522 - Disclosure - Commitments and Contingencies (Tables) Sheet http://royaltypharma.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://royaltypharma.com/role/CommitmentsandContingencies 38 false false R39.htm 9955523 - Disclosure - Related Party Transactions (Tables) Sheet http://royaltypharma.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://royaltypharma.com/role/RelatedPartyTransactions 39 false false R40.htm 9955524 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://royaltypharma.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://royaltypharma.com/role/SummaryofSignificantAccountingPoliciesPolicies 40 false false R41.htm 9955525 - Disclosure - Internalization - Narrative (Details) Sheet http://royaltypharma.com/role/InternalizationNarrativeDetails Internalization - Narrative (Details) Details 41 false false R42.htm 9955526 - Disclosure - Internalization - Summary of Total Purchase Consideration (Details) Sheet http://royaltypharma.com/role/InternalizationSummaryofTotalPurchaseConsiderationDetails Internalization - Summary of Total Purchase Consideration (Details) Details 42 false false R43.htm 9955527 - Disclosure - Internalization - Summary of Preliminary Allocation of Purchase Price (Details) Sheet http://royaltypharma.com/role/InternalizationSummaryofPreliminaryAllocationofPurchasePriceDetails Internalization - Summary of Preliminary Allocation of Purchase Price (Details) Details 43 false false R44.htm 9955528 - Disclosure - Internalization - Summary of Pro Forma Consolidated Information (Details) Sheet http://royaltypharma.com/role/InternalizationSummaryofProFormaConsolidatedInformationDetails Internalization - Summary of Pro Forma Consolidated Information (Details) Details 44 false false R45.htm 9955529 - Disclosure - Share-Based Compensation - Summary of Share-Based Compensation Expense (Details) Sheet http://royaltypharma.com/role/ShareBasedCompensationSummaryofShareBasedCompensationExpenseDetails Share-Based Compensation - Summary of Share-Based Compensation Expense (Details) Details 45 false false R46.htm 9955530 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://royaltypharma.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 46 false false R47.htm 9955531 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://royaltypharma.com/role/ShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 47 false false R48.htm 9955532 - Disclosure - Shareholders' Equity - Summary of Non-controlling Interests (Details) Sheet http://royaltypharma.com/role/ShareholdersEquitySummaryofNoncontrollingInterestsDetails Shareholders' Equity - Summary of Non-controlling Interests (Details) Details 48 false false R49.htm 9955533 - Disclosure - Available for Sale Debt Securities - Narrative (Details) Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecuritiesNarrativeDetails Available for Sale Debt Securities - Narrative (Details) Details 49 false false R50.htm 9955534 - Disclosure - Available for Sale Debt Securities - Summary of the Components of Funding Arrangement (Details) Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecuritiesSummaryoftheComponentsofFundingArrangementDetails Available for Sale Debt Securities - Summary of the Components of Funding Arrangement (Details) Details 50 false false R51.htm 9955535 - Disclosure - Available for Sale Debt Securities - Summary of Available for Sale Debt Securities (Details) Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesDetails Available for Sale Debt Securities - Summary of Available for Sale Debt Securities (Details) Details 51 false false R52.htm 9955536 - Disclosure - Fair Value Measurements and Financial Instruments - Summary of Fair Value Hierarchy (Details) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsSummaryofFairValueHierarchyDetails Fair Value Measurements and Financial Instruments - Summary of Fair Value Hierarchy (Details) Details 52 false false R53.htm 9955537 - Disclosure - Fair Value Measurements and Financial Instruments - Narrative (Details) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails Fair Value Measurements and Financial Instruments - Narrative (Details) Details http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsTables 53 false false R54.htm 9955538 - Disclosure - Fair Value Measurements and Financial Instruments - Summary of Change in Carrying Value of Level 3 Financial Instruments (Details) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsSummaryofChangeinCarryingValueofLevel3FinancialInstrumentsDetails Fair Value Measurements and Financial Instruments - Summary of Change in Carrying Value of Level 3 Financial Instruments (Details) Details 54 false false R55.htm 9955539 - Disclosure - Financial Royalty Assets - Summary of Financial Royalty Assets, Net (Details) Sheet http://royaltypharma.com/role/FinancialRoyaltyAssetsSummaryofFinancialRoyaltyAssetsNetDetails Financial Royalty Assets - Summary of Financial Royalty Assets, Net (Details) Details 55 false false R56.htm 9955540 - Disclosure - Financial Royalty Assets - Narrative (Details) Sheet http://royaltypharma.com/role/FinancialRoyaltyAssetsNarrativeDetails Financial Royalty Assets - Narrative (Details) Details 56 false false R57.htm 9955541 - Disclosure - Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets (Details) Sheet http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssetsDetails Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets (Details) Details http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssetsTables 57 false false R58.htm 9955542 - Disclosure - Non-Consolidated Affiliates (Details) Sheet http://royaltypharma.com/role/NonConsolidatedAffiliatesDetails Non-Consolidated Affiliates (Details) Details http://royaltypharma.com/role/NonConsolidatedAffiliates 58 false false R59.htm 9955543 - Disclosure - Research and Development Funding Expense (Details) Sheet http://royaltypharma.com/role/ResearchandDevelopmentFundingExpenseDetails Research and Development Funding Expense (Details) Details http://royaltypharma.com/role/ResearchandDevelopmentFundingExpense 59 false false R60.htm 9955544 - Disclosure - Borrowings - Summary of Borrowings (Details) Sheet http://royaltypharma.com/role/BorrowingsSummaryofBorrowingsDetails Borrowings - Summary of Borrowings (Details) Details 60 false false R61.htm 9955545 - Disclosure - Borrowings - Narrative (Details) Sheet http://royaltypharma.com/role/BorrowingsNarrativeDetails Borrowings - Narrative (Details) Details 61 false false R62.htm 9955546 - Disclosure - Borrowings - Summary of Repayments of Debt by Year (Details) Sheet http://royaltypharma.com/role/BorrowingsSummaryofRepaymentsofDebtbyYearDetails Borrowings - Summary of Repayments of Debt by Year (Details) Details 62 false false R63.htm 9955547 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://royaltypharma.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 63 false false R64.htm 9955548 - Disclosure - Earnings per Share - Summary of Earnings Per Share, Basic and Diluted (Details) Sheet http://royaltypharma.com/role/EarningsperShareSummaryofEarningsPerShareBasicandDilutedDetails Earnings per Share - Summary of Earnings Per Share, Basic and Diluted (Details) Details 64 false false R65.htm 9955549 - Disclosure - Indirect Cash Flow (Details) Sheet http://royaltypharma.com/role/IndirectCashFlowDetails Indirect Cash Flow (Details) Details http://royaltypharma.com/role/IndirectCashFlowTables 65 false false R66.htm 9955550 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://royaltypharma.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 66 false false R67.htm 9955551 - Disclosure - Commitments and Contingencies - Schedule of Future Lease Payments (Details) Sheet http://royaltypharma.com/role/CommitmentsandContingenciesScheduleofFutureLeasePaymentsDetails Commitments and Contingencies - Schedule of Future Lease Payments (Details) Details 67 false false R68.htm 9955552 - Disclosure - Related Party Transactions - Narrative (Details) Sheet http://royaltypharma.com/role/RelatedPartyTransactionsNarrativeDetails Related Party Transactions - Narrative (Details) Details 68 false false R69.htm 9955553 - Disclosure - Related Party Transactions - Summary of Distributions Payable to Non-controlling Interests (Details) Sheet http://royaltypharma.com/role/RelatedPartyTransactionsSummaryofDistributionsPayabletoNoncontrollingInterestsDetails Related Party Transactions - Summary of Distributions Payable to Non-controlling Interests (Details) Details 69 false false R70.htm 9955554 - Disclosure - Subsequent Event (Details) Sheet http://royaltypharma.com/role/SubsequentEventDetails Subsequent Event (Details) Details http://royaltypharma.com/role/SubsequentEvent 70 false false All Reports Book All Reports rprx-20250930.htm rprx-20250930.xsd rprx-20250930_cal.xml rprx-20250930_def.xml rprx-20250930_lab.xml rprx-20250930_pre.xml http://fasb.org/srt/2025 http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true